ArticleDiscover oncology2026

Interstitial lung disease during paclitaxel trastuzumab therapy enables safe trastuzumab rechallenge: a case report and review of the literature.

Zhaojun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.